{"url":"https://lda.senate.gov/api/v1/filings/dfefca91-b7a3-464b-ac8a-1cc3a0f4332f/","filing_uuid":"dfefca91-b7a3-464b-ac8a-1cc3a0f4332f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2013,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/dfefca91-b7a3-464b-ac8a-1cc3a0f4332f/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Peter Kiefhaber","dt_posted":"2013-07-19T11:14:54.990000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1301 Pennsylvania Ave., NW, Suite 500","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":62778,"url":"https://lda.senate.gov/api/v1/registrants/62778/","house_registrant_id":35395,"name":"RICCHETTI INCORPORATED","description":"Lobbying and consulting","address_1":"601 13th Street, NW","address_2":"Suite 830N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFF RICCHETTI","contact_telephone":"+1 202-879-9382","dt_updated":"2026-07-13T18:17:38.137744-04:00"},"client":{"id":162079,"url":"https://lda.senate.gov/api/v1/clients/162079/","client_id":710,"name":"SANOFI-AVENTIS U S INC","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2006-05-05"},"lobbying_activities":[{"general_issue_code":"ANI","general_issue_code_display":"Animals","description":"Issues related to compounding of veterinary drugs for animals.","foreign_entity_issues":"Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.","lobbyists":[{"lobbyist":{"id":30648,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"RICCHETTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate tax reform, extension of the R&D tax credit.","foreign_entity_issues":"Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.","lobbyists":[{"lobbyist":{"id":30648,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"RICCHETTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to patent litigation reforms.","foreign_entity_issues":"Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.","lobbyists":[{"lobbyist":{"id":30648,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"RICCHETTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ECN","general_issue_code_display":"Economics/Economic Development","description":"Issues related to the Global Investment in American Jobs Act of 2013.","foreign_entity_issues":"Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.","lobbyists":[{"lobbyist":{"id":30648,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"RICCHETTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to school access to emergency epinephrine;\nOutreach regarding the play-4 health program;\nIssues addressed in HR1919 (Safeguarding America's Pharmaceuticals Act of 2013).","foreign_entity_issues":"Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.","lobbyists":[{"lobbyist":{"id":30648,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"RICCHETTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to pharmaceutical reimbursement;\nIssues related to the expansion of Medicaid drug rebate;\nIssues related to the repeal if IPAB;\nIssues addressed in the Medicare Better Health Rewards Program Act of 2013;\nIssues related to coverage and reimbursement for those who are covered by Medicare/Medicaid;\nIssues related to the operation of the 340B program.","foreign_entity_issues":"Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so to Sanofi SA, as the parent company, will benefit.","lobbyists":[{"lobbyist":{"id":30648,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"RICCHETTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}